| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $449.9M | +6.2% | +17.7% |
| Cost of Revenue | $106.4M | +4.3% | +9.6% |
| Gross Profit | $343.4M | +6.8% | +20.5% |
| R&D Expense | $114.4M | +5.8% | +22.2% |
| SG&A Expense | $51.6M | +7.7% | +22.3% |
| Operating Income | $611K | +107.4% | +113.2% |
| Interest Expense | $6.3M | -0.6% | -3.4% |
| Pre-tax Income | $6.2M | +371.3% | +51.4% |
| Income Tax | -$1.6M | -103.0% | -107.5% |
| Net Income | $7.8M | +115.1% | +145.5% |
| EPS (Basic) | $0.07 | +114.6% | +143.8% |
| EPS (Diluted) | $0.07 | +114.6% | +143.8% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $737.2M | -7.9% | +26.2% |
| Short-term Investments | $510.8M | -14.2% | — |
| Accounts Receivable | $357.4M | +37.0% | +32.2% |
| Current Assets | $1.79B | -2.1% | +5.6% |
| Total Assets | $2.44B | -1.5% | +4.6% |
| Current Liabilities | $983.2M | +6.1% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $174.2M | — | — |
| Capital Expenditures | $2.2M | — | — |
| Investing Cash Flow | $121.7M | — | — |
| Financing Cash Flow | -$287.1M | — | — |
| Free Cash Flow | $172.0M | — | — |
| +17.5% |
| Long-term Debt | $570.6M | +0.1% | +0.2% |
| Total Liabilities | $1.65B | +3.9% | +12.0% |
| Stockholders' Equity | $791.0M | -11.2% | -7.9% |